Wei Xiaomu

Title: Innovations in Melanoma Diagnosis by Wei Xiaomu

Introduction

Wei Xiaomu is an accomplished inventor based in Ithaca, NY (US). He has made significant contributions to the field of melanoma research, particularly through his innovative patent related to genetic mutations.

Latest Patents

Wei Xiaomu holds a patent titled "GRIN2A mutations and use thereof for the diagnosis of melanoma." This patent describes the identification of 68 genes with an elevated frequency of somatic mutations in melanoma. Among these, the GRIN2A gene was found to be highly mutated, appearing in 34% of melanoma tumor samples. The study disclosed the identification of 34 different nonsynonymous somatic mutations in GRIN2A among 36 melanoma tumor samples. The patent also provides methods for diagnosing melanoma by detecting mutations in the TRRAP or GRIN2A genes, as well as selecting appropriate therapies based on these mutations.

Career Highlights

Wei Xiaomu is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work focuses on the genetic underpinnings of melanoma, contributing to advancements in diagnostic methods and treatment options.

Collaborations

One of his notable collaborators is Yardena Samuels, with whom he has worked on various research projects related to melanoma and genetic mutations.

Conclusion

Wei Xiaomu's innovative work in identifying genetic mutations associated with melanoma has the potential to significantly impact diagnosis and treatment strategies. His contributions to the field exemplify the importance of research in advancing medical science.